CYTO 2026 is centered on “The Next Wave” in cytometry: exciting new technologies, new capabilities, and what comes next. Yet for many labs, it means replacing instruments and rebuilding panels, often at the expense of value built over years.
What if it didn’t?
At this year’s conference, Stratedigm (Booth 408) will share a different approach: platforms designed to evolve with your work instead of forcing replacement.
Visit us to learn how teams are:
- Expanding capabilities without disrupting existing workflows
- Running both conventional and spectral analysis on the same system
- Extending the useful life of their cytometers by design, not by replacement cycles
If you’re evaluating what comes next, it’s worth comparing the long-term value of replacing vs. evolving your current system. Come talk with our team about what this could look like in your lab.
📍 Visit us at Booth 408 to meet our team and get an up-close look at the future of cytometry.
We can’t wait to show you what’s possible when innovation meets reliability.
Connect and continue the conversation with us on LinkedIn. To learn more about our future-proof instruments with investment protection, please contact in**@********gm.com, visit us at our website, or our YouTube Channel.